What's Going On With Hims & Hers Health Stock Tuesday?
What's Going On With Hims & Hers Health Stock Tuesday?
"In the third quarter, we eclipsed 2 million subscribers on our platform, with more than 1 million utilizing a personalized solution. These are significant milestones and confirm we are on a path to helping an American in every household feel great through the power of better health," said Hims & Hers Health Inc. (NYSE:HIMS) shares are trading higher Tuesday after the company reported strong third-quarter results and raised its full-year revenue outlook. Here's what you need to know.
Hims & Hers Hers Health Inc.（紐約證券交易所代碼：HIMS）週二股價走高，此前該公司公佈了強勁的第三季度業績並上調了全年收入展望。以下是你需要知道的。
What To Know: Hims & Hers Health reported third-quarter earnings per share of 32 cents, beating estimates of 4 cents. Revenue for the quarter reached $401.6 million, surpassing expectations of $382.2 million and marking a substantial rise from $226.7 million in the same period last year.
須知：Hims & Hers Health公佈的第三季度每股收益爲32美分，超過預期的4美分。該季度的收入達到4.016億美元，超過了預期的3.822億美元，較去年同期的2.267億美元大幅增長。
The company said its subscriber base has grown to 2 million, representing a 44% increase year-over-year. Gross margin for the third quarter was 79%. Hims & Hers also reported net income of $75.6 million, representing a significant turnaround from the $7.6 million net loss reported in third quarter of 2023.
該公司表示，其用戶群已增長到200萬，同比增長44％。第三季度的毛利率爲79％。Hims & Hers還公佈了7,560萬美元的淨收入，與2023年第三季度公佈的760萬美元淨虧損相比有了重大轉機。
"In the third quarter, we eclipsed 2 million subscribers on our platform, with more than 1 million utilizing a personalized solution. These are significant milestones and confirm we are on a path to helping an American in every household feel great through the power of better health," said Andrew Dudum, co-founder and CEO of Hims & Hers Health.
「在第三季度，我們在平台上的訂閱人數超過了200萬，其中超過100萬人使用了個性化解決方案。這些都是重要的里程碑，證實我們正在通過改善健康的力量幫助每個家庭的美國人感覺良好。」 Hims & Hers Health聯合創始人兼首席執行官安德魯·杜杜姆說。
Hims & Hers raised its fiscal 2024 revenue guidance to $1.46 billion to $1.465 billion, versus estimates of $1.396 billion. The company said it expects fourth-quarter revenue to range between $465 million and $470 million.
Hims & Hers將其2024財年的收入預期上調至14.6億美元至14.65億美元，而估計爲13.96億美元。該公司表示，預計第四季度收入將在4.65億美元至4.7億美元之間。
Following the print, Canaccord Genuity analyst Maria Ripps maintained Hims & Hers Health with a Buy rating and raised the price target from $24 to $28.
印發後，Canaccord Genuity分析師瑪麗亞·裏普斯以買入評級維持Hims & Hers Hers的健康，並將目標股價從24美元上調至28美元。
Hims Price Action: Hims & Hers shares were up 5.39% at $21.89 at the time of writing, according to Benzinga Pro.
他的價格走勢：根據Benzinga Pro的數據，在撰寫本文時，Hims & Hers的股價上漲了5.39％，至21.89美元。
- '30% Less Than Blue': Swing State Home Prices Align With Red States, Says Realtor.com
- 「比藍州低30％」：Realtor.com表示，搖擺州房價與紅州一致
Image: Mohamed Hassan from Pixabay.
圖片：來自 Pixabay 的穆罕默德·哈桑。
譯文內容由第三人軟體翻譯。
